Currently, Mark I. Froimson is Chairman at Lazurite Holdings LLC. Dr. Froimson is also on the board of SINTX Technologies, Inc., Pacira Biosciences, Inc. and The Arthritis Foundation and Principal at Riverside Health Advisors LLC.

In the past Mark I. Froimson occupied the position of Vice Chairman & Member-Governors Board at Cleveland Clinic Orthopedic & Rheumatologic Institute, President & Chief Executive Officer at Euclid Hospital, President of American Association of Hip & Knees Surgeons and Chief Clinical Officer & Executive Vice President at Trinity Health Corp.

Dr. Froimson received an undergraduate degree from Princeton University, a doctorate from Tulane University School of Medicine and an MBA from Weatherhead School of Management.